Power Law company profile

Relay Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2016 · IPO 2020 Unicorn

A new breed of company at the intersection of computation and biotechnology that is committed to creating medicines that will have a transformative impact on patients

Valuation

$1.96B

Market cap · May/2026

Revenue

$15M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

12 investors on Relay Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Third Rock Ventures

Series B+ 11 investors entered at this stage

Tavistock Group

Foresight Group

Alexandria Venture Investments

Nextech

EcoR1 Capital

BVF Partners

Global footprint

Where Relay Therapeutics has talent and traffic

Workforce by country

5 countries with
team presence

🇺🇸 United States98.7%

🇰🇷 South Korea0.5%

🇮🇳 India0.5%

🇨🇦 Canada0.4%

🇫🇷 France0.4%

5 countries shown

Web traffic by country

13K monthly visits
across markets

🇺🇸 United States53.8%

🇮🇳 India18.5%

🇬🇧 United Kingdom15.4%

🇯🇵 Japan9.2%

🇩🇪 Germany1.5%

Top 5 markets shown

Patent intelligence

$14M patent portfolio · 37 active families

Estimated portfolio value

$14M

0.69% of market cap · 1.9× smaller than top peer Kymera Therapeutics ($26M)

37 active patent families

Where Relay Therapeutics innovates BiochemistryPharmacologyMolecular biologyPhosphatase inhibitorDepressant

Where Relay Therapeutics concentrates vs peers

Each axis is a top-10 topic across Relay Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Relay Therapeutics

An AI-synthesized read of the highest-engagement posts about Relay Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Relay Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles